知识 首页 人类健康 知识 All 观点 论文 科普 面谈 过滤 Therapeutic areasCOVID-19消化健康 Apply 首页 人类健康 知识 Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19 首页 人类健康 知识 Preclinical evaluation of PHH-1V candidate against SARS-CoV-2 in non-human primates 首页 人类健康 知识 Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate 首页 人类健康 知识 Clone of Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate 首页 人类健康 知识 Clone of Clone of Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate 首页 人类健康 知识 Clone of Clone of Clone of Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate 首页 人类健康 知识 Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2 首页 人类健康 知识 Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial 首页 人类健康 知识 Safety and immunogenicity of PHH-1V as booster vaccination through the Omicron era: results from a phase IIb open-label extension study up to 6 months 加载更多
